From professional translators, enterprises, web pages and freely available translation repositories.
postmarketing
vaistui pasirodzius rinkoje gauti duomenys
Last Update: 2008-03-04
Usage Frequency: 5
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
postmarketing experience
patirtis po patekimo į rinką
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ed postmarketing experience
ot duomenys apie rinkoje esantį vaistinį preparatą
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
# postmarketing adverse reaction
# nepageidaujama reakcija gauta po vaistinio preparato patekimo į rinką
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
psychiatric disorders * postmarketing experience.
lytinės sistemos sutrikimai psichikos sutrikimai
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
clinical trial data and postmarketing data
klinikinių tyrimų duomenys ir po vaistinio preparato patekimo į rinką gauti duomenys
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
reactions observed from the postmarketing environment
nepageidaujamos reakcijos pastebėtos į rinką tiekiamo vaisto stebėjimo metu (pms)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
based on postmarketing experience with canagliflozin.
remiantis duomenimis kanagliflozinui patekus į rinką.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
* events identified during postmarketing surveillance
padidėjęs tyrimai šarminės fosfatazės ir alt kiekis * nepageidaujamos reakcijos nustatytos įdiegus vaistą į rinką bei atlikus vaisto poveikio stebėjimo tyrimus.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
adverse reactions from prevenar 13 postmarketing experience
nepageidaujamos reakcijos, nustatytos po prevenar 13 patekimo į rinką
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
adverse reactions reported during postmarketing experience.
nepageidaujamos reakcijos registruotos preparatui jau esant rinkoje.
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
additional adverse reactions from postmarketing spontaneous reporting
Širdies sustojimas, tachikardija
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
serious adverse reactions based on postmarketing experience.
sunkios nepageidaujamos reakcijos, vykusios po vaisto vedimo rink
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
postmarketing experience from clinical trials and spontaneous reports
patirtis vaistinį preparatą pateikus į rinką (iš klinikinių tyrimų ir savanoriškų pranešimų)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a derived from postmarketing experience b see section 4.4
a gauta po vaistinio preparato registracijos b žr. 4.4 skyrių
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there have been postmarketing reports of elevated liver enzymes.
vaistui esant rinkoje buvo gauti pranešimai apie kepenų fermentų koncentracijos padidėjimą.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
adverse drug reactions reported in clinical trials and postmarketing experience
klinikinių tyrimų metu ir po vaistinio preparato patekimo į rinką pasireiškusios nepageidaujamos reakcijos
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in postmarketing, serious allergic reactions including anaphylaxis have been reported
tyrimo, įdiegus vaistą į rinką, metu sunkios alerginės reakcijos, įskaitant anafilaksiją, susijusios su humira vartojimu, pastebėtos labai retai.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
the following events have been reported spontaneously during postmarketing experience:
vaistui pasirodzius rinkoje, gauta spontanini pranesim apie zemiau nurodytus nepageidaujamus reiskinius:
Last Update: 2008-03-04
Usage Frequency: 5
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
12 additional adverse reactions from postmarketing surveillance or phase iv clinical trials
vaisto poveikio stebjimo arba iv fazs klinikini tyrim metu atsiradusios papildomos nepageidaujamos reakcijos
Last Update: 2008-03-04
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.